Dried spots on filter paper made of whole blood (dried blood spots; DBS), plasma (dried plasma spots; DPS) or serum (dried serum spots) hold promise as an affordable and practical alternative specimen source to liquid plasma for HIV type-1 (HIV-1) viral load determination and drug resistance genotyping in the context of the rapidly expanding access to antiretroviral therapy (ART) for HIV-1-infected individuals in low- and middle-income countries. This report reviews the current evidence for their utility.
Methods
We systematically searched the English language literature published before 2009 on Medline, the websites of the World Health Organization and US Centers for Disease Control and Prevention, abstracts presented at relevant international conferences and references from relevant articles.
Results
Data indicate that HIV-1 viral load determination and resistance genotyping from DBS and DPS is feasible, yielding comparable test performances, even after storage. Limitations include reduced analytical sensitivity resulting from small analyte volumes (approximately 3.5 log10 copies/ ml at 50 ml sample volume), nucleic acid degradation under extreme environmental conditions, impaired efficiency of nucleic acid extraction, potential interference of archived proviral DNA in genotypes obtained from DBS and the excision of spots from the filters in high-volume testing.
Conclusions
This technology offers the advantages of a stable specimen matrix, ease of sample collection and shipment. The current sensitivity in drug resistance testing is appropriate for public health surveillance among pretreatment populations. However, consistently improved analytical sensitivity is needed for their routine application in the therapeutic monitoring of individuals receiving ART, particularly at the onset of treatment failure.
References
1.
PalellaF.J.Jr., DelaneyK.M., MoormanA.C.Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.N Engl J Med1998; 338: 853–860.
2.
HammerS.M., EronJ.J.Jr., ReissP.Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel.JAMA2008; 300: 555–570.
3.
CroweS., TurnbullS., OelrichsR., DunneA.Monitoring of human immunodeficiency virus infection in resource-constrained countries.Clin Infect Dis2003; 37 Suppl 1: S25–S35.
McCabeE.R., HuangS.Z., SeltzerW.K., LawM.L.DNA microextraction from dried blood spots on filter paper blotters: potential applications to newborn screening.Hum Genet1987; 75: 213–216.
6.
MeiJ.V., AlexanderJ.R., AdamB.W., HannonW.H.Use of filter paper for the collection and analysis of human whole blood specimens.J Nutr2001; 131: 1631S–1636S.
7.
HoffR., BerardiV.P., WeiblenB.J., Mahoney-TroutL., MitchellM.L., GradyG.F.Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns.N Engl J Med1988; 318: 525–530.
8.
GwinnM., PappaioanouM., GeorgeJ.R.Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples.JAMA1991; 265: 1704–1708.
9.
EvengardB., EhrnstA., von SydowM., PehrsonP.O., LundberghP., LinderE.Effect of heat on extracted HIV viral infectivity and antibody activity using the filter paper technique of blood sampling.AIDS1989; 3: 591–595.
10.
ComeauA.M., PittJ., HillyerG.V.Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group.J Pediatr1996; 129: 111–118.
11.
ShermanG.G., StevensG., JonesS.A., HorsfieldP., StevensW.S.Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings.J Acquir Immune Defic Syndr2005; 38: 615–617.
12.
StevensW., ErasmusL., MoloiM., TalengT., SarangS.Performance of a novel human immunodeficiency virus (HIV) type 1 total nucleic acid-based real-time PCR assay using whole blood and dried blood spots for diagnosis of HIV in infants.J Clin Microbiol2008; 46: 3941–3945.
13.
Alvarez-MunozM.T., Zaragoza-RodriguezS., Rojas-MontesO.High correlation of human immunodeficiency virus type-1 viral load measured in dried-blood spot samples and in plasma under different storage conditions.Arch Med Res2005; 36: 382–386.
14.
AyeleW., SchuurmanR., MesseleT.Use of dried spots of whole blood, plasma, and mother's milk collected on filter paper for measurement of human immunodeficiency virus type 1 burden.J Clin Microbiol2007; 45: 891–896.
15.
BrambillaD., JenningsC., AldrovandiG.Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability.J Clin Microbiol2003; 41: 1888–1893.
16.
FiscusS.A., BrambillaD., GrossoL., SchockJ., CroninM.Quantitation of human immunodeficiency virus type 1 RNA in plasma by using blood dried on filter paper.J Clin Microbiol1998; 36: 258–260.
17.
KaneC.T., NdiayeH.D., DialloS.Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal.J Virol Methods2008; 148: 291–295.
18.
MwabaP., CassolS., NunnA.Whole blood versus plasma spots for measurement of HIV-1 viral load in HIV-infected African patients.Lancet2003; 362: 2067–2068.
19.
O'SheaS., MullenJ., CorbettK., ChrystieI., NewellM.L., BanatvalaJ.E.Use of dried whole blood spots for quantification of HIV-1 RNA.AIDS1999; 13: 630–631.
20.
UttayamakulS., LikanonsakulS., SunthornkachitR.Usage of dried blood spots for molecular diagnosis and monitoring HIV-1 infection.J Virol Methods2005; 128: 128–134.
21.
WatersL., KambuguA., TibenderanaH.Evaluation of filter paper transfer of whole-blood and plasma samples for quantifying HIV RNA in subjects on antiretroviral therapy in Uganda.J Acquir Immune Defic Syndr2007; 46: 590–593.
22.
AmellalB., KatlamaC., CalvezV.Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification.HIV Med2007; 8: 396–400.
23.
CassolS., GillM.J., PilonR.Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper.J Clin Microbiol1997; 35: 2795–2801.
24.
IdigbeE.O., EkongE.E., SaluO.B.Primagen retina TM rainbow viral load assay: a feasible for assay for resource limited settings- the Nigerian experience.2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. 13–16 July 2003, Paris, France. Abstract LB38.
25.
AbravayaK.S.H., EricksonB., MakW.B.The use of dried blood spots with the Abbott RealTime HIV-1 viral load assay.XVII International AIDS Conference. 3–8 August 2008, Mexico City, Mexico. Abstract CDB0034.
26.
AbdoM., ShermanG., StevensW.Validation of the NucliSens EasyQ assay on dried fluid spots for monitoring of HIV-1 infection in South Africa.15th Conference on Retroviruses and Opportunistic Infections. 3–6 February 2008, Boston, MA, USA: Abstract 925.
27.
BertagnolioS., Soto-RamirezL., PilonR.HIV-1 drug resistance surveillance using dried whole blood spots.Antivir Ther2007; 12: 107–113.
28.
BucktonA.J., BissettS.L., MyersR.E.Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.J Antimicrob Chemother2008; 62: 1191–1198.
29.
DachraouiR., BrandD., BrunetS., BarinF., PlantierJ.C.RNA amplification of the HIV-1 pol and env regions on dried serum and plasma spots.HIV Med2008; 9: 557–561.
30.
DachraouiR., DepatureauxA., ChakrounM.Monitoring of HIV-1 resistance in Tunisia (North Africa) with a dried plasma spot strategy.J Acquir Immune Defic Syndr2008; 47: 522–525.
31.
GarridoC., ZahoneroN., FernandesD.Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola.J Antimicrob Chemother2008; 61: 694–698.
32.
HallackR., DohertyL.E., WethersJ.A., ParkerM.M.Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay.J Clin Virol2008; 41: 283–287.
33.
MasciotraS., GarridoC., YoungpairojA.S.High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.AIDS2007; 21: 2503–2511.
34.
McNultyA., JenningsC., BennettD.Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing.J Clin Microbiol2007; 45: 517–521.
SteegenK., LuchtersS., DemecheleerE.Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots.J Clin Microbiol2007; 45: 3342–3351.
37.
YoungpairojA.S., MasciotraS., GarridoC., ZahoneroN., de MendozaC., Garcia-LermaJ.G.HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C.J Antimicrob Chemother2008; 61: 1217–1220.
38.
ZiemniakC., George-AgwuA., MossW.J., RayS.C., PersaudD.A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.J Virol Methods2006; 136: 238–247.
39.
KnuchelM.C., TomasikZ., SpeckR.F., LuthyR., SchupbachJ.Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings.J Clin Virol2006; 36: 64–67.
40.
StevensG., RekhviashviliN., ScottL.E., GoninR., StevensW.Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.J Clin Microbiol2005; 43: 857–861.
41.
MwabaP., CassolS., PilonR.Use of dried whole blood spots to measure CD4+ lymphocyte counts in HIV-1-infected patients.Lancet2003; 362: 1459–1460.
NoeA., PlumJ., VerhofstedeC.The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance.J Antimicrob Chemother2005; 55: 410–412.
44.
VerhofstedeC., NoeA., DemecheleerE.Drug-resistant variants that evolve during nonsuppressive therapy persist in HIV-1-infected peripheral blood mononuclear cells after long-term highly active antiretroviral therapy.J Acquir Immune Defic Syndr2004; 35: 473–483.
45.
BiX., GatanagaH., IdaS.Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year.J Acquir Immune Defic Syndr2003; 34: 1–6.
46.
BruistenS.M., ReissP., LoeligerA.E.Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons.AIDS Res Hum Retroviruses1998; 14: 1053–1058.
47.
ChunT.W., CarruthL., FinziD.Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.Nature1997; 387: 183–188.
48.
EscaichS., RitterJ., RougierP.Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals.AIDS Res Hum Retroviruses1992; 8: 1833–1837.
49.
DriverG.A., PattonJ.C., MoloiJ., StevensW.S., ShermanG.G.Low risk of contamination with automated and manual excision of dried blood spots for HIV DNA PCR testing in the routine laboratory.J Virol Methods2007; 146: 397–400.
50.
AkaneA., MatsubaraK., NakamuraH., TakahashiS., KimuraK.Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification.J Forensic Sci1994; 39: 362–372.
51.
BoomR., SolC.J., SalimansM.M.Rapid and simple method for purification of nucleic acids.J Clin Microbiol1990; 28: 495–503.
